174 related articles for article (PubMed ID: 16868132)
21. The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.
Bartalena L
J Clin Endocrinol Metab; 2011 Mar; 96(3):592-9. PubMed ID: 21190983
[TBL] [Abstract][Full Text] [Related]
22. Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids.
Menconi F; Marinò M; Pinchera A; Rocchi R; Mazzi B; Nardi M; Bartalena L; Marcocci C
J Clin Endocrinol Metab; 2007 May; 92(5):1653-8. PubMed ID: 17299076
[TBL] [Abstract][Full Text] [Related]
23. A questionnaire survey on the management of Graves' orbitopathy in China: A comparison with Europe and Latin-America.
Xu SH; Li XJ; Chen GF; Zheng QX; Yang Y; Hu YX; Wang K; Liu C
Chronic Dis Transl Med; 2015 Jun; 1(2):117-123. PubMed ID: 29062996
[TBL] [Abstract][Full Text] [Related]
24. Which factors are associated with quality of life in patients with Graves' orbitopathy presenting for orbital decompression surgery?
Wickwar S; McBain HB; Ezra DG; Hirani SP; Rose GE; Newman SP
Eye (Lond); 2015 Jul; 29(7):951-7. PubMed ID: 25998940
[TBL] [Abstract][Full Text] [Related]
25. Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures.
; Mourits MP; Bijl H; Altea MA; Baldeschi L; Boboridis K; Currò N; Dickinson AJ; Eckstein A; Freidel M; Guastella C; Kahaly GJ; Kalmann R; Krassas GE; Lane CM; Lareida J; Marcocci C; Marino M; Nardi M; Mohr Ch; Neoh C; Pinchera A; Orgiazzi J; Pitz S; Saeed P; Salvi M; Sellari-Franceschini S; Stahl M; von Arx G; Wiersinga WM
Br J Ophthalmol; 2009 Nov; 93(11):1518-23. PubMed ID: 19028743
[TBL] [Abstract][Full Text] [Related]
26. [Graves' orbitopathy].
Eckstein A; Esser J
Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
[TBL] [Abstract][Full Text] [Related]
27. Management of sinonasal complications after endoscopic orbital decompression for Graves' orbitopathy.
Antisdel JL; Gumber D; Holmes J; Sindwani R
Laryngoscope; 2013 Sep; 123(9):2094-8. PubMed ID: 23839980
[TBL] [Abstract][Full Text] [Related]
28. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.
Bartalena L; Baldeschi L; Dickinson A; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits M; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas GE; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM;
Eur J Endocrinol; 2008 Mar; 158(3):273-85. PubMed ID: 18299459
[No Abstract] [Full Text] [Related]
29. Early versus late orbital decompression in Graves' orbitopathy: a retrospective study in 125 patients.
Baldeschi L; Wakelkamp IM; Lindeboom R; Prummel MF; Wiersinga WM
Ophthalmology; 2006 May; 113(5):874-8. PubMed ID: 16530839
[TBL] [Abstract][Full Text] [Related]
30. Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.
Perros P; Hegedüs L; Bartalena L; Marcocci C; Kahaly GJ; Baldeschi L; Salvi M; Lazarus JH; Eckstein A; Pitz S; Boboridis K; Anagnostis P; Ayvaz G; Boschi A; Brix TH; Currò N; Konuk O; Marinò M; Mitchell AL; Stankovic B; Törüner FB; von Arx G; Zarković M; Wiersinga WM
Orphanet J Rare Dis; 2017 Apr; 12(1):72. PubMed ID: 28427469
[TBL] [Abstract][Full Text] [Related]
31. Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy.
Marcocci C; Marinò M
Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):325-37. PubMed ID: 22632369
[TBL] [Abstract][Full Text] [Related]
32. [Endocrine orbitopathy: the present view of a clinical endocrinologist].
Jiskra J
Vnitr Lek; 2017; 63(10):690-696. PubMed ID: 29127744
[TBL] [Abstract][Full Text] [Related]
33. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
Juri J; Stiglmayer N; Kuzman T
Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
[TBL] [Abstract][Full Text] [Related]
34. Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways.
Perros P; Dayan CM; Dickinson AJ; Ezra D; Estcourt S; Foley P; Hickey J; Lazarus JH; MacEwen CJ; McLaren J; Rose GE; Uddin J; Vaidya B
Clin Med (Lond); 2015 Apr; 15(2):173-8. PubMed ID: 25824071
[TBL] [Abstract][Full Text] [Related]
35. Management of patients with Graves' orbitopathy: initial assessment, management outside specialized centres and referral pathways.
Orgiazzi J
Clin Endocrinol (Oxf); 2016 May; 84(5):662-3. PubMed ID: 26866718
[No Abstract] [Full Text] [Related]
36. Endoscopic orbital decompression for Graves' ophthalmopathy.
Kasperbauer JL; Hinkley L
Am J Rhinol; 2005; 19(6):603-6. PubMed ID: 16402649
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and side effects of 'swinging eyelid' orbital decompression in Graves' orbitopathy: a proposal for standardized evaluation of diplopia.
Paridaens D; Lie A; Grootendorst RJ; van den Bosch WA
Eye (Lond); 2006 Feb; 20(2):154-62. PubMed ID: 15746952
[TBL] [Abstract][Full Text] [Related]
38. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey.
Estcourt S; Hickey J; Perros P; Dayan C; Vaidya B
Eur J Endocrinol; 2009 Sep; 161(3):483-7. PubMed ID: 19542244
[TBL] [Abstract][Full Text] [Related]
39. Pediatric aspects in Graves' orbitopathy.
Gogakos AI; Boboridis K; Krassas GE
Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():234-44. PubMed ID: 20467370
[TBL] [Abstract][Full Text] [Related]
40. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
